The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
Notice for pemigatinib (Specialised Therapeutics Alim Pty Ltd)
Active ingredients
pemigatinib
Date of review outcome
Lapse date
Type
Orphan drug
Dosage form(s)
Immediate release tablet
Indication
Treatment of cholangiocarcinoma (CCA)
Therapeutic area
Oncology